Trans fatty acids: Effects on cardiometabolic health and implications for policy

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 79, Issue 3-5, 2008, Pages 147-152

  Micha, R ^b   Mozaffarian, D ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cardiovascular; Coronary heart disease; Diet; Nutrition; Policy; Review; Trans fatty acids

Indexed keywords

CARBOHYDRATE; CONJUGATED LINOLENIC ACID; HIGH DENSITY LIPOPROTEIN; LINOLENIC ACID; LOW DENSITY LIPOPROTEIN; MONOUNSATURATED FATTY ACID; OLEIC ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; TRANS FATTY ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VACCENIC ACID;

ARTICLE; ATTRIBUTABLE RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL FUNCTION; CLINICAL TRIAL; COHORT ANALYSIS; DEVELOPING COUNTRY; DIET SUPPLEMENTATION; DIETARY INTAKE; DISEASE EXACERBATION; ENDOTHELIUM; FAT INTAKE; FATTY ACID ANALYSIS; FEASIBILITY STUDY; FOOD COMPOSITION; FOOD PROCESSING; HEALTH CARE POLICY; HEALTH EDUCATION; HEART INFARCTION; HEART MUSCLE METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INTRAABDOMINAL FAT; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SIDE EFFECT; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CARDIOVASCULAR DISEASES; FOOD LABELING; HEALTH POLICY; HUMANS; INSULIN RESISTANCE; PUBLIC POLICY; RISK FACTORS; TRANS FATTY ACIDS;

EID: 56449123210     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plefa.2008.09.008     Document Type: Article

References (58)

1. American Heart Association, Heart Disease and Stroke Statistics-2004 Update. 〈www.americanheart.org〉, 2004 (accessed 28.04.2004) pp. 25-26.
2. Mozaffarian D., et al. Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation 117 9 (2008) 1130-1137
3. Mozaffarian D. Effects of dietary fats versus carbohydrates on coronary heart disease: a review of the evidence. Curr. Atheroscler. Rep. 7 6 (2005) 435-445
4. Allison D.B., et al. Estimated intakes of trans fatty and other fatty acids in the US population. J. Am. Diet. Assoc. 99 2 (1999) 166-174
5. Mozaffarian D., et al. Consumption of trans fats and estimated effects on coronary heart disease in Iran. Eur. J. Clin. Nutr. 61 (2007) 1004-1010
6. Stender S., Dyerberg J., and Astrup A. High levels of industrially produced trans fat in popular fast foods. N. Engl. J. Med. 354 15 (2006) 1650-1652
7. Dietary Guidelines Advisory Committee. 2005 Dietary Guidelines Advisory Committee Report (2005) [cited 12.09. 2005]; Available from: 〈http://www.health.gov/dietaryguidelines/dga2005/report/〉.
8. Innis S.M., Green T.J., and Halsey T.K. Variability in the trans fatty acid content of foods within a food category: implications for estimation of dietary trans fatty acid intakes. J. Am. Coll. Nutr. 18 3 (1999) 255-260
9. Lock A.L., and Bauman D.E. Modifying milk fat composition of dairy cows to enhance fatty acids beneficial to human health. Lipids 39 12 (2004) 1197-1206
10. Riserus U., et al. Effects of cis-9, trans-11 conjugated linoleic acid supplementation on insulin sensitivity, lipid peroxidation and proinflammatory markers in obese men. Am. J. Clin. Nutr. 80 2 (2004) 279-283
11. Moloney F., et al. Conjugated linoleic acid supplementation, insulin sensitivity and lipoprotein metabolism in patients with type 2 diabetes mellitus. Am. J. Clin. Nutr. 80 4 (2004) 887-895
12. Smedman A., Vessby B., and Basu S. Isomer-specific effects of conjugated linoleic acid on lipid peroxidation in humans: regulation by alpha-tocopherol and cyclo-oxygenase-2 inhibitor. Clin. Sci. (London) 106 1 (2004) 67-73
13. Nugent A.P., et al. The effects of conjugated linoleic acid supplementation on immune function in healthy volunteers. Eur. J. Clin. Nutr. 59 6 (2005) 742-750
14. Oomen C.M., et al. Association between trans fatty acid intake and 10-year risk of coronary heart disease in the Zutphen Elderly Study: a prospective population-based study. Lancet 357 9258 (2001) 746-751
15. Pietinen P., et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The alpha-tocopherol, beta-carotene cancer prevention study. Am. J. Epidemiol. 145 10 (1997) 876-887
16. Willett W.C., et al. Intake of trans fatty acids and risk of coronary heart disease among women. Lancet 341 8845 (1993) 581-585
17. Jakobsen M.U., et al. Intake of ruminant trans fatty acids and risk of coronary heart disease. Int. J. Epidemiol. 37 1 (2008) 173-182
18. Mozaffarian D., and Clarke R. Quantitative effects on cardiovascular risk factors and coronary heart disease risk of replacing partially hydrogenated vegetable oils with other fats and oils. Eur. J. Clin. Nutr. (2008) (in press)
19. Mozaffarian D., et al. Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 354 15 (2006) 1601-1613
20. Sun Q., et al. A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115 14 (2007) 1858-1865
21. Mensink R.P., et al. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 77 5 (2003) 1146-1155
22. Ascherio A., et al. Trans fatty acids and coronary heart disease. N. Engl. J. Med. 340 25 (1999) 1994-1998
23. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 9 (2002) 1135-1143
24. Albert C.M., et al. Prospective study of C-reactive protein, homocysteine and plasma lipid levels as predictors of sudden cardiac death. Circulation 105 22 (2002) 2595-2599
25. Pickup J.C. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27 3 (2004) 813-823
26. Vasan R.S., et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107 11 (2003) 1486-1491
27. Mozaffarian D., et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am. J. Clin. Nutr. 79 4 (2004) 606-612
28. Lopez-Garcia E., et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J. Nutr. 135 3 (2005) 562-566
29. Baer D.J., et al. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am. J. Clin. Nutr. 79 6 (2004) 969-973
30. Han S.N., et al. Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J. Lipid Res. 43 3 (2002) 445-452
31. Ridker P.M., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 12 (2000) 836-843
32. de Roos N.M., Bots M.L., and Katan M.B. Replacement of dietary saturated fatty acids by trans fatty acids lowers serum HDL cholesterol and impairs endothelial function in healthy men and women. Arterioscler. Thromb. Vasc. Biol. 21 7 (2001) 1233-1237
33. Koh-Banerjee P., et al. Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption and smoking with 9-y gain in waist circumference among 16,587 US men. Am. J. Clin. Nutr. 78 4 (2003) 719-727
34. Field A.E., et al. Dietary fat and weight gain among women in the Nurses' health study. Obesity (Silver Spring) 15 4 (2007) 967-976
35. Kavanagh K., et al. Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity (Silver Spring) 15 7 (2007) 1675-1684
36. Louheranta A.M., et al. A high-trans fatty acid diet and insulin sensitivity in young healthy women. Metabolism 48 7 (1999) 870-875
37. Lefevre M., et al. Comparison of the acute response to meals enriched with cis- or trans-fatty acids on glucose and lipids in overweight individuals with differing FABP2 genotypes. Metabolism 54 12 (2005) 1652-1658
38. Albuquerque K.T., et al. Intake of trans fatty acid-rich hydrogenated fat during pregnancy and lactation inhibits the hypophagic effect of central insulin in the adult offspring. Nutrition 22 7-8 (2006) 820-829
39. Mozaffarian D., and Willett W.C. Trans fatty acids and cardiovascular risk: a unique cardiometabolic imprint?. Curr. Atheroscler. Rep. 9 6 (2007) 486-493
40. Clandinin M.T., et al. Dietary fat: exogenous determination of membrane structure and cell function. Faseb. J. 5 13 (1991) 2761-2769
41. Feller S.E., and Gawrisch K. Properties of docosahexaenoic-acid-containing lipids and their influence on the function of rhodopsin. Curr. Opin. Struct. Biol. 15 4 (2005) 416-422
42. Roach C., et al. Comparison of cis and trans fatty acid containing phosphatidylcholines on membrane properties. Biochemistry 43 20 (2004) 6344-6351
43. Vanden Heuvel J.P. Diet, fatty acids and regulation of genes important for heart disease. Curr. Atheroscler. Rep. 6 6 (2004) 432-440
44. Saravanan N., et al. Differential effects of dietary saturated and trans-fatty acids on expression of genes associated with insulin sensitivity in rat adipose tissue. Eur. J. Endocrinol. 153 1 (2005) 159-165
45. Dashti N., et al. Trans polyunsaturated fatty acids have more adverse effects than saturated fatty acids on the concentration and composition of lipoproteins secreted by human hepatoma HepG2 cells. J. Nutr. 132 9 (2002) 2651-2659
46. Mitmesser S.H., and Carr T.P. Trans fatty acids alter the lipid composition and size of apoB-100-containing lipoproteins secreted by HepG2 cells. J. Nutr. Biochem. 16 3 (2005) 178-183
47. Matthan N.R., et al. Hydrogenated fat consumption affects acylation-stimulating protein levels and cholesterol esterification rates in moderately hypercholesterolemic women. J. Lipid Res. 42 11 (2001) 1841-1848
48. Mozaffarian D., Aro A., and Willett W.C. Health effects of trans-fatty acids: experimental and observational evidence. Eur. J. Clin. Nutr. (2008) (in press)
49. Health Canada. Government response to the interim recommendations of the trans fat task force (2005) [cited 20.09.2005]; Available from: 〈http://www.hc-sc.gc.ca/fn-an/nutrition/gras-trans-fats/government_response_reponse_gouvernement_e.html〉.
50. Food and Drug Administration, Food labeling: Trans fatty acids in nutrition labeling, nutrient content claims, and health claims, in Federal Register, Department of Health and Human Services, Editor. 2003.
51. Ban Trans Fats. The campaign to ban partially hydrogenated oils (2003) [cited 16.08.2008]; Available from: 〈http://www.bantransfats.com/index.html〉.
52. Kraft Foods. Kraft foods reformulates hundreds of US products as part of voluntary trans fat reduction efforts (2005) [cited 16.08.2008]; Available from: 〈http://www.kraft.com/MediaCenter/country-press-releases/us/2005/us_pr_12202005.html〉.
53. Leth T., et al. The effect of the regulation on trans fatty acid content in Danish food. Atheroscler. Suppl. 7 2 (2006) 53-56
54. New York City Department of Health and Mental Hygiene. Healthy Heart-Avoid Trans Fat (2007) [cited 26.01.2008]; Available from: 〈http://www.nyc.gov/html/doh/html/cardio/cardio-transfat.shtml〉.
55. Mozaffarian D. Trans fatty acids-effects on systemic inflammation and endothelial function. Atheroscler. Suppl. 7 2 (2006) 29-32
56. New York City Department of Health and Mental Hygiene. Press release: 94% of inspected restaurants in compliance with first phase of trans fat regulation (2007) [cited 15.10.2007]; Available from: 〈http://www.nyc.gov/html/doh/html/pr2007/pr080-07.shtml〉.
57. Colon-Ramos U., et al. Translating research into action: a case study on trans fatty acid research and nutrition policy in Costa Rica. Health Policy Plan 22 6 (2007) 363-374
58. Mauger J.F., et al. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am. J. Clin. Nutr. 78 3 (2003) 370-375